Life ScienceCompany
Impact Biomedicines Ownership
Who owns Impact Biomedicines?
Impact Biomedicines is owned by Celgene. It was acquired on January 7, 2018.
Impact Biomedicines Business Overview
Where is Impact Biomedicines headquartered?
Impact Biomedicines is headquartered in San Diego, California.
What sector is Impact Biomedicines in?
Impact Biomedicines is a life science company.
When was Impact Biomedicines founded?
Impact Biomedicines was founded in 2016.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.